|
SOCS6 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.618200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.199400E-01 |
| Normal-vs-Stage2 |
6.640600E-01 |
| Normal-vs-Stage3 |
5.646900E-04 |
| Normal-vs-Stage4 |
3.897000E-03 |
| Stage1-vs-Stage2 |
7.419600E-01 |
| Stage1-vs-Stage3 |
9.200500E-04 |
| Stage1-vs-Stage4 |
2.562100E-03 |
| Stage2-vs-Stage3 |
1.397220E-01 |
| Stage2-vs-Stage4 |
1.167440E-01 |
| Stage3-vs-Stage4 |
8.021800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.751500E-02 |
| Normal-vs-AfricanAmerican |
1.617890E-02 |
| Normal-vs-Asian |
2.842200E-01 |
| Caucasian-vs-AfricanAmerican |
2.486600E-01 |
| Caucasian-vs-Asian |
9.832300E-02 |
| AfricanAmerican-vs-Asian |
2.585700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.036300E-03 |
| Normal-vs-Female |
6.552600E-01 |
| Male-vs-Female |
4.182000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.999900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.890400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.099520E-02 |
| Normal-vs-Age(81-100Yrs) |
2.398800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.785380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.660800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.180000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.430240E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.137200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.029400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.112800E-01 |
| Normal-vs-Grade 2 |
8.843400E-01 |
| Normal-vs-Grade 3 |
2.764300E-02 |
| Normal-vs-Grade 4 |
8.39420000176005E-09 |
| Grade 1-vs-Grade 2 |
5.568800E-01 |
| Grade 1-vs-Grade 3 |
1.350400E-01 |
| Grade 1-vs-Grade 4 |
5.616100E-04 |
| Grade 2-vs-Grade 3 |
2.493600E-02 |
| Grade 2-vs-Grade 4 |
7.34799998625135E-09 |
| Grade 3-vs-Grade 4 |
1.804390E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.401600E-01 |
| Normal-vs-ccB subtype |
5.993900E-04 |
| ccA subtype-vs-ccB subtype |
1.63500000005534E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.356590E-01 |
| Normal-vs-N1 |
3.628200E-01 |
| N0-vs-N1 |
6.118800E-01 |
|
|
